Market Overview

United States Coronary Embolic Protection Device Market 2018-2024: Units Sold, Average Selling Prices, Product Pipeline & Forecasts - ResearchAndMarkets.com

Share:

The "Coronary
Embolic Protection Device Market | US | Units Sold, Average Selling
Prices, Product Pipeline, Forecasts | 2018-2024 | MedCore"

report has been added to ResearchAndMarkets.com's
offering.

Recent clinical data has shown that the use of an embolic protection
device during interventional procedures, especially SVG angioplasties,
greatly reduces the occurrence of complications such as strokes. The
reason for this is that strokes after interventional procedures are
usually caused by the dislodging of plaque attached to the vessel wall
that travel through the vasculature and cause a blockage in a smaller
vessel.

Key Topics Covered:

1. RESEARCH METHODOLOGY

2. DISEASE OVERVIEW

2.1 BASIC ANATOMY

2.2 DISEASE TREATMENTS AND DIAGNOSTICS

2.2.1 General Diagnostics

2.2.2 Coronary Artery Disease (CAD)

2.2.3 Myocardial Infarction (MI)

2.2.4 Angina Pectoris

2.3 PATIENT DEMOGRAPHICS

2.3.1 General Statistics

3. CORONARY EMBOLIC PROTECTION DEVICE MARKET

3.1 INTRODUCTION

3.1.1 Saphenous Vein Grafts

3.1.2 Protection Mechanism

3.1.2.1 Filter Basket

3.1.2.2 Distal Balloon Occlusion

3.2 MARKET ANALYSIS AND FORECAST

3.3 DRIVERS AND LIMITERS

3.3.1 Market Drivers

3.3.2 Market Limiters

3.4 COMPETITIVE MARKET SHARE ANALYSIS

Abbreviations

Appendix I: Company Press Releases

Companies Mentioned:

  • Boston Scientific
  • Abbott Laboratories
  • Medtronic
  • Philips
  • Terumo
  • Cardinal Health
  • Merit Medical Systems
  • Cook Medical
  • Asahi Intecc
  • Teleflex
  • Cardiovascular Systems Inc.
  • Galt Medical
  • C.R. Bard
  • Angiodynamics
  • ACIST Medical Systems
  • Infraredx
  • Tryton Medical
  • B. Braun
  • Maquet

For more information about this report visit https://www.researchandmarkets.com/research/bpkwx5/united_states?w=4

View Comments and Join the Discussion!